Related Experiment Video
Updated: Oct 2, 2025
11:02
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
684
Metabolomics and its Applications in Cancer Cachexia
Pengfei Cui1, Xiaoyi Li2, Caihua Huang3
1College of Food and Pharmacy, Xuchang University, Xuchang, China.
Frontiers in Molecular Biosciences
|February 24, 2022
Summary
Cancer cachexia (CC) involves complex metabolic changes and muscle wasting in many patients. This review explores how metabolomics research over the last decade enhances understanding of CC
Area of Science:
- Biochemistry
- Oncology
- Metabolomics
Background:
- Cancer cachexia (CC) is a debilitating metabolic syndrome characterized by muscle wasting, affecting 50-80% of cancer patients.
- The underlying molecular mechanisms of CC are not fully understood, hindering effective treatment strategies.
Purpose of the Study:
- To review the research progress and applications of metabolomics in understanding cancer cachexia over the past decade.
- To provide a theoretical foundation for the prediction, early diagnosis, and therapeutic development for CC.
Main Methods:
- Systematic review of scientific literature focusing on metabolomics studies related to cancer cachexia published in the last 10 years.
- Analysis of identified metabolic shifts, altered metabolite concentrations, and disturbed metabolic pathways in CC progression.
Main Results:
- Metabolomics has revealed significant metabolic alterations and pathway disturbances associated with cancer cachexia.
- These findings contribute to a deeper fundamental understanding of muscle loss mechanisms in cancer patients.
Conclusions:
- Metabolomics offers valuable insights into the complex molecular landscape of cancer cachexia.
- This review establishes a basis for future research in CC prediction, early diagnosis, and targeted therapies.
